Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Here's the beginning of a new podcast with my friend, Dr. Gerard Silvestri, who is a pulmonologist at the Medical University of South Carolina (MUSC) in Charleston. He did a live webinar with us a few months ago, co-sponsored by GRACE and the LUNGevity Foundation, on the topic of pulmonary complications from lung cancer treatment, with the first part of his presentation focusing on chemotherapy-induced pneumonitis (lung inflammation), which we haven't spent a lot of time talking about.
Here's the first podcast from his presentation, in both video and audio podcast formats, as well as the transcript and figures from the program.
Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Audio Podcast
Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Transcript
Dr. Silvestri Pulm Complications LC Treatment Chemo Pneumonitis Figs
We'll continue with further discussion of lung-related complications from treatment of lung cancer in the next podcast, which will cover targeted therapies.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…